Orange Book product · Generic (ANDA)
NALOXONE HYDROCHLORIDE
NALOXONE HYDROCHLORIDE
At a glance
Jul 19, 1988
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 19, 1988
38 yr 6 mo ago
Today
Pharmaceutical detail
Active ingredient
NALOXONE HYDROCHLORIDE
Strength
0.4MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
ANDA 071811
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of NALOXONE HYDROCHLORIDE
- 2024NALOXONE HYDROCHLORIDEGeneric (ANDA)
ANDA 213573 · FRESENIUS KABI USA
- 2024NALOXONE HYDROCHLORIDEGeneric (ANDA)
ANDA 212300 · HIKMA
- 2023NALOXONE HYDROCHLORIDEGeneric (ANDA)
ANDA 216977 · BPI LABS
- 2022NALOXONE HYDROCHLORIDEGeneric (ANDA)
ANDA 214792 · BAXTER HLTHCARE CORP
- 2022NALOXONE HYDROCHLORIDEGeneric (ANDA)
ANDA 216624 · ACCORD HLTHCARE
- 2021NALOXONE HYDROCHLORIDEGeneric (ANDA)
ANDA 214785 · BAXTER HLTHCARE CORP
- 2021NALOXONE HYDROCHLORIDEGeneric (ANDA)
ANDA 213279 · EUGIA PHARMA
- 2020NALOXONE HYDROCHLORIDEGeneric (ANDA)
ANDA 213209 · DR REDDYS
- 2019NALOXONE HYDROCHLORIDEGeneric (ANDA)
ANDA 212456 · EUGIA PHARMA
- 2019NALOXONE HYDROCHLORIDEGeneric (ANDA)
ANDA 212455 · EUGIA PHARMA
- 2018NALOXONE HYDROCHLORIDEGeneric (ANDA)
ANDA 207846 · CHARTWELL RX
- 1989NALOXONE HYDROCHLORIDEGeneric (ANDA)
ANDA 072081 · ASTRAZENECA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
